Skip to main content

This job has expired

You will need to login before you can apply for a job.

Associate Director, Investor Relations

Employer
Nurix Therapeutics
Location
San Francisco, CA
Start date
Jan 4, 2022

View more

Discipline
Administration, Marketing, Public Relations, General
Required Education
Bachelors Degree
Position Type
Full time
Hotbed
Biotech Bay

Job Details


Company

Nurix Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. Leveraging Nurix’s extensive expertise in E3 ligases together with its proprietary DNA-encoded libraries, Nurix has built DELigase, an integrated discovery platform to identify and advance novel drug candidates targeting E3 ligases, a broad class of enzymes that can modulate proteins within the cell. Nurix’s drug discovery approach is to either harness or inhibit the natural function of E3 ligases within the ubiquitin proteasome system to selectively decrease or increase cellular protein levels.

Nurix’s wholly owned pipeline comprises targeted protein degraders of Bruton’s tyrosine kinase, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, an E3 ligase that regulates T cell activation. Nurix is headquartered in San Francisco, California.


The Position

The Associate Director of Corporate Affairs and Investor Relations will report to the Head of Investor Relations and key internal stakeholders, investors and analysts as well as our investor relations and public relations agencies to build Nurix’s identity, reputation and visibility. The position involves engaging key internal and external audiences, creating powerful messages, storylines and communications which drive awareness for Nurix and its platform technologies and drug candidates. 


Job Responsibilities

Investor Relations

  • Manage participation in investor focused events and conferences, including materials creation, conference registration and management team preparation
  • Create and maintain IR calendar
  • Facilitate timely follow up on investor inquiries and requests for meetings
  • In association with department S.V.P., prepare key written investor materials: corporate presentation, press releases, quarterly earnings scripts and related Q/A documents
  • Direct and execute on investor events including an annual Analyst Day meeting and investor meetings at medical conferences

Corporate Communications

  • Quality-check documents for press releases and key media announcements.
  • Manage approval process for external communications
  • Manage corporate website, updating and editing as required
  • Work with investor relations and public relations agency

Required Qualifications

  • 5 - 7+ years of experience in related position with demonstrated results
  • Exceptional communication skills across an organization and with strong working relationships with senior leadership
  • Strong attention to detail and proactive with consistent follow through
  • Ability to understand science and medical terminology and to translate that into communication to lay audiences
  • Excellent verbal, written and presentation skills
  • B.A./B.S. Communications, Journalism, Biology or related field is desirable

Fit with Nurix Culture and Values

  • Strong team orientation; highly collaborative
  • Solutions and results-oriented focus
  • Hands-on approach; resourceful and open to diverse points of view

Application Process

Nurix is an Equal Opportunity Employer offering a competitive salary and benefits package. Applicants should be legally entitled to work for any employer in the US.


Note to Employment Agencies: Please do not forward any agency resumes. Nurix will not be responsible for fees related to unsolicited resumes.

Company

Nurix Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. Leveraging Nurix’s extensive expertise in E3 ligases together with its proprietary DNA-encoded libraries, Nurix has built DELigase, an integrated discovery platform to identify and advance novel drug candidates targeting E3 ligases, a broad class of enzymes that can modulate proteins within the cell. Nurix’s drug discovery approach is to either harness or inhibit the natural function of E3 ligases within the ubiquitin proteasome system to selectively decrease or increase cellular protein levels.

Nurix’s wholly owned pipeline comprises targeted protein degraders of Bruton’s tyrosine kinase, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, an E3 ligase that regulates T cell activation. Nurix is headquartered in San Francisco, California.

Company info
Website
Phone
415-660-5320
Location
1700 Owens Street
Suite 205
San Francisco
California
94158
US

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert